Table of Contents Author Guidelines Submit a Manuscript
Journal of Nucleic Acids
Volume 2010, Article ID 850234, 10 pages
http://dx.doi.org/10.4061/2010/850234
Research Article

Selective Incision of the - -Methyl-Formamidopyrimidine Anomer by Escherichia coli Endonuclease IV

Departments of Chemistry and Biochemistry, Center in Molecular Toxicology, Vanderbilt University, VU Station B 351822, Nashville, N 37235-1822, USA

Received 13 April 2010; Accepted 4 June 2010

Academic Editor: Ashis Basu

Copyright © 2010 Plamen P. Christov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Formamidopyrimidines (Fapy) lesions result from ring opening of the imidazole portion of purines. Fapy lesions can isomerize from the natural -anomeric stereochemistry to the -configuration. We have unambiguously demonstrated that the -methyl-Fapy-dG (MeFapy-dG) lesion is a substrate for Escherichia coli Endonuclease IV (Endo IV). Treatment of a MeFapy-dG-containing 24 mer duplex with Endo IV resulted in 36–40% incision. The catalytic efficiency of the incision was comparable to that of -dG in the same duplex sequence. The - and -MeFapy-dG anomers equilibrate to ~21 : 79 ratio over ~3 days. Related studies with a duplex containing the -Fapy-dG lesion derived from aflatoxin B1 epoxide ( -AFB-Fapy-dG) showed only low levels of incision. It is hypothesized that the steric bulk of the aflatoxin moiety interferes with the binding of the substrate to Endo IV and the incision chemistry.

1. Introduction

Formamidopyrimidines (Fapy) are DNA lesions that result from ring opening of the imidazole portion of purines. Fapy lesions derived from dG can form by either initial oxidation or N7-alkylation of the guanine base (Scheme 1) [16]. These are structurally related lesions that differ by the substitution at the -formamide. The formyl nitrogen of the Fapy-dG derived from oxidative damage is unsubstituted, and it has been proposed that recognition of this lesion by human OGG involves hydrogen-bonding interactions between the protein and this functional group [7]. The formyl nitrogen is substituted with the alkylating agent from the alkylative pathway, and this substitution is likely to change the conformation of the adduct and its interaction with repair proteins and DNA polymerases. The corresponding Fapy-dG adducts were shown to be the persistent DNA lesions resulting from exposure to methylating agents (MeFapy-dG) and aflatoxin B1 (AFB-Fapy-dG) [810].

850234.sch.001
Scheme 1: Fapy-dG lesions derived from oxidative or alkylative damage to dG.

An unusual property of Fapy lesions is that the stereochemistry can interconvert between the - and -anomers. This presumably occurs through the N6- imine intermediate [11, 12]; the pyranose form can also result at the nucleoside level [13, 14]. The -anomer of dA, dT, and dC results from -radiolysis of DNA [15, 16]; however, the -stereochemistry of these lesions is static once it is formed.

Escherichia coli Endonuclease IV (Endo IV) is a double-strand specific AP endonuclease that hydrolyzes the phosphodiester bond on the -side of abasic sites and accounts for ~10% of the AP endonuclease activity in E. coli [1719]. The incision of the damaged strand results in a 5′-terminal ribosyl- -phosphate on the downstream fragment and a free -hydroxyl group of the upstream fragment. Endo IV also possesses -diesterase activity and can remove -blocking groups such as -phosphates, -phosphoglycolate, and the -(4-hydroxy-2-pentenal)-5-phosphate group that results from -elimination of abasic sites. Endo IV was also found to possess exonuclease activity and can generate a single base gap at the -side of a damaged base [20, 21]. Endo IV contains three Zn2+ atoms in its active site and recognizes the damage site by a double nucleotide-flipping mechanism [2224]. Oligonucleotides containing the -dA, -dT, -dC, -Fapy-dA, and -Fapy-dG lesions as well as the configurationally stable -carbon Fapy analogues -C-Fapy-dA have been shown to be substrates for Endo IV [2529]. Oligonucleotides containing MeFapy-dG have also been examined as potential substrates for Endo IV. Asagoshi et al.reported that a MeFapy-dG-containing oligonucleotide was not a substrate for Endo IV and concluded that this lesion existed as the -MeFapy-dG anomer [30, 31]. However,Ishchenko et al.[32] reported incision of the MeFapy-dG lesion with a catalytic efficiency comparable to that reported for -C-Fapy-dA [29]. Interestingly, evidence that Endo IV plays a role in the repair of deoxyribosylurea lesions has also been reported [33]; this lesion can also undergo anomerization, and it is likely that the -anomer is a substrate for Endo IV [3436].

We recently described the synthesis of a phosphoramidite reagent of the MeFapy-dG lesion and its utility in the site-specific synthesis of modified oligonucleotides [11]. Two transitions were observed in the thermal melting curve of a 12-mer duplex containing a MeFapy-dG lesion. The lower melting transition was assigned as the -MeFapy-dG anomer and the higher melting transition as the -anomer. These assignments were based on a similar thermal melting profile of the AFB-Fapy-dG adduct for which the conformations of the - and -anomers (Scheme 2) have been determined by NMR [37, 38]. The anomeric ratio of the MeFapy-dG adduct was estimated to be ~40 : 60. We report here the selective incision of the -MeFapy-dG anomer from duplex DNA by Endo IV.

850234.sch.002
Scheme 2: The - and -anomers of Fapy-dG.

2. Materials and Methods

-dG was purchased from Berry and Associates, Inc. and was converted to its phosphoramidite reagent using standard protocols [39]. T4 polynucleotide kinase and E. coli Endo IV were purchased from New England Biolabs. -32P-ATP was purchased from PerkinElmer Life Sciences. Unmodified oligonucleotides were purchased from Midland Certified Reagents. MALDI-TOF mass spectra were recorded using a 3-hydroxypicolinic acid (HPA) and ammonium hydrogen citrate matrix.

Oligonucleotide Synthesis
The MeFapy-dG and AFB-Fapy-dG modified oligonucleotides were synthesized as previously described [11, 40]. The -dG-containing oligonucleotide was synthesized via the phosphoramidite method. The purity of all oligonucleotides was judged to be >99% by capillary gel electrophoresis. Oligonucleotides were characterized by MALDI-TOF mass spectrometry and enzymatic digestion.

-ACCACGCTAGC-( -MeFapy-dG)-AGTCCTAACAAC-
It was purified by reversed-phase HPLC using gradient 1 and further purified by PAGE. MALDI-TOF MS (HPA) m/z calcd for (M-H), 7304.4; found 7305.4.

-ACCACGCTAGC-( -dG)-AGTCCTAACAAC-
It was purified by reversed-phase HPLC using gradient 2. MALDI-TOF MS (HPA) m/z calcd for (M-H), 7272.2; found 7272.3.

-ACCACTACTAT-( -AFB-Fapy-dG)-ATTCATAACAAC-
It was purified by reverse-phase HPLC using gradient 3. MALDI-TOF MS (HPA) m/z calcd for (M-H), 7593.2; found 7594.1.

HPLC Purification
A YMC ODS-AQ column (250 × 4.6 mm, flow rate 1.5 mL/min; 250 × 10 mm, flow rate 5 mL/min) or Phenomenex Gemini-C18 column (250 × 4.6 mm, flow rate 1.5 mL/min; 250 × 10 mm, flow rate 5 mL/min) was used for oligonucleotide purifications and to monitor reactions. Oligonucleotides were detected by their UV absorbance at 254 nm. The mobile phase consisted of CH3CN and 100 mM ammonium formate buffer (v/v).

Gradient 1
Initial conditions were 1% CH3CN; a linear gradient to 8% CH3CN over 5 minute; a linear gradient to 13% CH3CN over 15 minute; a linear gradient to 80% CH3CN over 2 minute; isocratic at 80% CH3CN for 2 minute; then a linear gradient to the initial conditions over 3 minute.

Gradient 2
Initial conditions were 1% CH3CN; a linear gradient to 5% CH3CN over 5 minute; a linear gradient to 10% CH3CN over 15 minute; a linear gradient to 80% CH3CN over 2 minute; isocratic at 80% CH3CN for 2 minute; then a linear gradient to the initial conditions over 3 minute.

Gradient 3
Initial conditions were 6% CH3CN; a linear gradient to 25% CH3CN over 25 minute; a linear gradient to 80% CH3CN over 2 minute; isocratic at 80% CH3CN for 2 minute; then a linear gradient back to the initial conditions over 3 minute.

LC-ESI-MS Analysis
MS analysis was performed in the Vanderbilt University facility on a Waters Acquity UPLC system connected to a Finnigan LTQ mass spectrometer (ThermoElectron) equipped with an Ion Max API source and a standard electrospray probe using an Acquity UPLC BEH C18 column ( , 1.0 mm × 100 mm). LC conditions were as follows: buffer contained 10 mM NH4CH3CO2 plus 2% CH3CN (v/v), and buffer contained 10 mM NH4CH3CO2 plus 95% CH3CN (v/v). The following gradient program was used with a flow rate of L/min: initially 0%   , 3 minute linear gradient to 3%   , 1.5 minute linear gradient to 20%   , 0.5 minute linear gradient to 100%   , isocratic at 100%   for 0.5 minute, 1 minute linear gradient to 0%   , and isocratic at 0%   for 3 minute. The temperature of the column was maintained at , and the samples (10  L) were infused with an autosampler. The electrospray conditions were as follows: source voltage: 4 kV; source current: 100  A; N2 was used as the auxiliary gas at a flow rate setting of 20; sweep gas flow-rate setting, 5: sheath gas flow setting: 34; capillary voltage: −49 V; capillary temperature, ; and tube lens voltage: −90 V. The automatic gain control (AGC) setting in full MS was 10000. The maximum injection time in full MS was 10 ms. The MS data were acquired in negative mode. The number of scan used for data acquisition in full MS was 2. Product ion spectra were acquired over the range of m/z 345–2000.

Oligonucleotide Labeling and Annealing
The labeling of the MeFapy-dG oligonucleotide was performed as previously described using T4 polynucleotide kinase and -32P-ATP [41]. Electrophoresis gels were exposed to a PhosphorImager screen (Imaging Screen , Bio-Rad) overnight. The bands were visualized with a PhosphorImaging system (Bio-Rad, Molecular Imager FX) using the manufacturer’s Quantity One software, version 4.3.0. Unless otherwise noted, the oligonucleotide duplexes were formed by annealing the -32P-labeled MeFapy-dG-containing oligonucleotide (200 nM) with its complementary strand (600 nM) in Tris buffer (100  L, 50 mM, pH 8.0) at for 5 minute; the solution was then slowly cooled to ambient temperature over 1 h.

Time Course Incision of the MeFapy-dG and α-dG-Containing Duplexes by Endo IV
The oligonucleotide duplex (4  L, 0.8 pmols) was added to the Endo IV reaction buffer (74  L of 1X : 100 mM NaCl, 50 mM Tris-HCL, 10 mM MgCl2, and 1 mM dithiothreitol, pH 7.9) and warmed to . Endo IV (0.08 nM) was added; aliquots (5  L) were removed at the appropriate times, added to 10  L of 95% formamide loading buffer containing xylene cyanol and bromophenol blue dyes, and heated for 1 minute at C. Aliquots (6  L) from the samples were separated by electrophoresis on a denaturing gel.
To determine the extent of background deglycosylation of the lesion, aliquots of the MeFapy-dG-containing oligonucleotide were treated with 0.1 M NaOH and incubated at C for 20 minute. The samples were neutralized by addition of 0.1 M HCl, diluted with loading buffer, and analyzed by gel electrophoresis. The amount of the cleavage in this control experiment was subtracted from the amount of incision in the Endo IV reactions. Reactions were carried out in duplicate. The same procedure was used for the incision of the -32P-labeled α-dG-containing duplex.

Incision of the -AFB-Fapy-dG-Containing Duplex by Endo IV
The -32P-labeled -AFB-Fapy-dG oligonucleotide (120 nM) was annealed to its complementary strand (160 nM) in Tris buffer (100  L, 50 mM, pH 8.0) at room temperature. Aliquots (10  L, 120 nM) were taken every 5 minute and added to a mixture of Endo IV enzyme buffer (10X, 6  L), water (40  L), and Endo IV (0.4 nM) at C; the incision reactions were incubated at C and pH 7.9. Aliquots (5  L) were taken every 2 minute and added to 10  L of 95% formamide loading buffer containing xylene cyanol and bromophenol blue dyes and heated for 1 minute at C. Aliquots (6  L) were separated by electrophoresis on a denaturing gel. The extent of background deglycosylation of the -AFB-Fapy-dG lesion was determined as described above. The amount of the cleavage in the control experiment was subtracted from the amount of incision in the Endo IV reactions. Reactions were carried out in duplicate.

Kinetics for the Incision of the MeFapy-dG- and -dG-Containing Duplexes by Endo IV
The duplex was annealed as described above with the following modifications. The -32P-labeled MeFapy-dG and its complementary strand were 100 and 150 nM, respectively. Endo IV (0.08 nM) was added to varying concentrations of the DNA duplex (0.5–35 nM in 1X Endo IV reaction buffer, pH 7.9) to a final volume 50  L. Reactions were run at C for up to 10 minute. Aliquots (5  L) were taken at 1 minute intervals, added to loading buffer (10  L), and heated at C for 1 minute. Separation was achieved by gel electrophoresis. The kinetics parameters were calculated using KaleidaGraph 4.0. Reactions were carried out in duplicate. The same procedure was used for incision of the -dG-containing duplex.

Time Course Incision of the MeFapy-dG-Containing Duplex by Endo IV at pH 7.0
The oligonucleotide duplex (12  L, 2.4 pmols) was added to the Endo IV reaction buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1 mM dithiothreitol, pH 7, 222  L), followed by addition of Endo IV (0.08 nM). The reaction was incubated at C for 5 days. A fresh portion of Endo IV (0.08 nM) was added every 24 h. Aliquots (5  L) were removed 30 minute after the Endo IV addition, added to 10  L of 95% formamide loading buffer containing xylene cyanol and bromophenol blue dyes, and heated for 1 minute at C. The incision reaction was analyzed by gel electrophoresis. The experiment was run in duplicate.

Incision of the MeFapy-dG-Containing Duplex after Denaturation and Reannealing
The DNA duplex was formed as described above with the following modifications. The -32P-labeled MeFapy-dG and its complementary strand were 200 and 400 nM, respectively. The oligonucleotide duplex (8  L, 1.6 pmols) was added to 1X Endo IV reaction buffer (148  L), followed by addition of Endo IV (0.08 nM). The reaction was run at C for 40 minute and aliquots (5  L) were removed periodically, added to 10  L of 95% formamide loading buffer containing xylene cyanol and bromophenol blue dyes and heated for 1 minute at C. The remaining reaction mixture was heated at C for 5 minute, cooled to C for 30 minute, then cooled to ambient temperature over 1 h. The reannealed DNA duplex incubated at C and Endo IV (0.08 nM) was added. Aliquots were taken as previously described, and the level of incision was analyzed by gel electrophoresis. The denaturation and reannealing cycles were repeated one more time.

LC-ESI-MS Analysis of the Incision of the MeFapy-dG-Containing Duplex by Endo IV
MeFapy-dG-containing 24 mer oligonucleotide (0.774 nmol) was annealed to its complimentary strand (1.5 eq., 1.161 nmol) in Tris buffer (100  L, 50 mM, pH 8.0) as described above. To this solution Endo IV reaction buffer (13  L, 10X) was added followed by addition of Endo IV (0.8 nM). The reaction mixture was incubated at C for 2 h. The reaction mixture was then passed through a spin column (Bio-spin 6 Tris columns) and lyophilized. The white residue was dissolved in water and analyzed by LC-ESI-MS.

Incision of the MeFapy-dG-Containing Duplex by Endo IV at pH 7.0
The DNA duplex was annealed as described above in Tris buffer (50 mM, pH 7.0). The oligonucleotide duplex (12  L, 2.4 pmols) was added to the Endo IV reaction buffer (222  L, 100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, and 1 mM dithiothreitol, pH 7.0). The reaction was incubated at C. Aliquots (50  L) were removed after 1, 3, 5, 7, and 10 days and treated with Endo IV (0.08 nM). Aliquots (8  L) were added to 10  L of 95% formamide loading buffer containing xylene cyanol and bromophenol blue dyes and heated for 1 minute at C. The experiment was run in duplicate.

Thermal Melting ( ) Analysis of the MeFapy-dG-Containing 12 mer Duplex
A 1 : 1 mixture of MeFapy-dG containing 12 mer oligonucleotide and its complementary strand (0.25 A260 units) were placed in melting buffer (0.5 mL, 10 mM Na2HPO4/NaH2PO4, 1.0 M NaCl, and 50  M Na2EDTA, pH 7.2). The UV absorbance of the duplex was monitored 260 nm as a function of temperature. Absorbance measurements were taken at 1 minute intervals with a C/min temperature gradient. The temperature was cycled between 15 and C. The first derivative of the melting curve was used to establish values. After running the first , the sample was incubated at C for 5 days, then experiment was repeated.

3. Results and Discussion

3.1. Incision of MeFapy-dG-Containing Duplex by Endo IV

The MeFapy-dG lesion was site specifically incorporated at position 12 of the 24 mer oligonucleotide shown in Figure 2 (X = MeFapy-dG) and annealed to its complementary strand. The activity of Endo IV toward the MeFapy-dG lesion when paired with dC was examined. PAGE analysis of the reaction mixture typically showed between 36% and 40% of the -32P-ACCACGCTAGC- incision product after 30 minute (Figure 2(a)). Increasing the initial concentration of Endo IV or addition of a second portion of enzyme after the initial 30 minute incubation period did not increase the amount of incised product. The incision reaction was also followed by LC-ESI-MS with nonradiolabeled oligonucleotides (Figure 3). In addition to the MeFapy-dG-containing oligonucleotide (m/z = 1825.4 [M-4H] and 1460.3 [M-5H]) and its complementary strand (m/z = 1484.9 [M-5H] and 1237.2 [M-6H]), the -ACCACGCTAGC- (m/z = 1094.1 [M-3H] and 820.3 [M-4H]) and -p(MeFapy-dG)-AGTCCTAACAAC- (m/z = 1345.2 [M-3H] and 1009.0 [M-4H]) incision products were observed.

After the initial incision of the MeFapy-dG-containing duplex, the remaining 24 mer duplex, which was presumably highly enriched in the -MeFapy-dG anomer, was denatured by heating to C, then slowly cooled to reanneal the duplex. The heating and annealing cycle is expected to equilibrate the - and -anomers of the MeFapy-dG lesion [29]. Additional Endo IV was added and the -32P-ACCACGCTAGC- incision product was found to be ~59% (Figure 2(b)); the 23% increase of the incision products represents ~36% cleavage of the MeFapy-dG duplex remaining (64%) after the initial Endo IV incision. A subsequent denaturation-reannealing cycle followed by addition of a third aliquot of Endo IV resulted in an additional 14% increase of the incision product (73% total), representing ~34% cleavage of the MeFapy-dG-containing duplex remaining after the prior two rounds of Endo IV treatment (41%). These results are similar to those reported by Patro et al. for the incision of the Fapy-dA containing duplex and is consistent with selective incision of the -MeFapy-dG anomer [29].

The MeFapy-dG-containing oligonucleotide was also hybridized to complementary strands in which the lesion was mismatched with dG, dA, and dT. Treatment of these duplexes with Endo IV and PAGE analysis resulted in 30%, 32%, and 30% incision, respectively. The reactions products from the mismatched duplexes were also characterized by LC-ESI-MS analyses.

3.2. Steady-State Analysis for the Endo IV Incision of the MeFapy-dG-Containing Duplex

Figure 4 shows the steady-state kinetic analysis for the incision of MeFapy-dG strand when paired with dC. The modified strand was incised with a  min-1 and  nM (  nM-1 min-1; filled circles). When the DNA concentration used in the rate calculation was adjusted to reflect only the amount of the -MeFapy-dG adduct (~40%, open circles), the catalytic efficiency improved to  nM-1 min-1 by virtue of a lower (  nM). This treatment of the rate data assumes that the -MeFapy-dG-containing duplex does not inhibit Endo IV and is based on the observation that the incision of duplex DNA containing -dA was not inhibited by the addition of an unmodified duplex, even at concentrations 30-fold higher than the substrate DNA [25]. For comparison, the phosphoramidite reagent of -dG was prepared and incorporated into the same 24 mer sequence; -dG was chosen for this comparison because of the commercial availability of the nucleoside. The catalytic efficiency for the incision of the -dG-containing duplex ( ) was  nM-1 min-1 (  min-1 and  nM) (Figure 4 (b)).

3.3. Equilibration of the MeFapy-dG Anomers in DNA

The -MeFapy-dG lesion was excised from the 24 mer duplex, and the equilibration of the remaining -MeFapy-dG to a mixture of - and -anomers was monitored at C (Figure 5). Aliquots were taken every 24 h after the initial incision reaction and additional Endo IV was added; the increase in the -32P-ACCACGCTAGC- was attributed to the anomerization of the -MeFapy-dG remaining after initial incision. The prolonged exposure of the incision product to Endo IV resulted in its conversion to a product one nucleotide shorter. We attribute this observation to the exonuclease activity of Endo IV, and the product is presumably -32P-ACCACGCTAG- [20]. Virtually no anomerization was observed at pH 8.0, consistent with studies that showed that the anomerization of the AFB-Fapy-dG lesion was acid catalyzed [40]. We found that the anomeric stereochemistry of the -MeFapy-dG equilibrated over ~5 days to an ratio of ~21 : 79 at pH 7.0 and C. To insure that the additional cleavage of the duplex was not due to fortuitous deglycosylation of the MeFapy-G base, the MeFapy-dG-containing duplex was incubated at C for 5 days, then E. coli Endonuclease V was added, which is known to cleave abasic sites. No cleavage was observed.

The duplex that resulted from annealing the MeFapy-dG modified oligonucleotide with its complement initially contained ~36%–40% of the -MeFapy-dG. The equilibration of the -MeFapy-dG anomer to the -anomer was monitored by incubating the annealed duplex at C and treating aliquots with Endo IV (Figure 5 (b)). We observed that the anomeric ratio was ~30 : 70 after 24 h and 23 : 77 after 3 days; the reaction was monitored up to 10 days, and the percentage of incision product remained at ~23%. These results are in good agreement with those starting from the -anomer.

We initially reported that the thermal melting ( ) curve of a 12 mer duplex containing the MeFapy-dG lesion did not change over time [11]; these studies were conducted at C. The thermal melting temperature of the 12 mer duplex -GCTAGC-(MeFapy-dG)-AGTCC- -GGACTCGCTAGC- was reexamined by monitoring the hyperchromicity of the DNA UV absorption at 260 nm as a function of temperature (Figure 6). This duplex has the same local sequence as the 24 mer duplex used for the Endo IV incision studies. The duplex was incubated at C for 5 days then analyzed. The values were determined by taking the first derivative of the melting and annealing curves. As previously reported, two transitions were present in the melting cycle; however, the relative proportions of the transitions differed after 5 days at C. The higher melting transition (  =  C), which was assigned as the -MeFapy-dG anomer, made up ~80% of the duplex after the incubation period. The curve for the annealing cycle was displaced from the heating cycle, reflecting that the reannealing of the MeFapy-dG oligonucleotide with its complement resulted in a different anomeric ratio than after equilibration for 5 days. Similar melting and annealing profiles were recently reported for a duplex containing the AFB-Fapy-dG lesion [38]. These studies are consistent with the Endo IV incision data.

The initial anomeric ratio (~36 : 64) after annealing the MeFapy-dG-containing oligonucleotide with its complement may reflect the ratio in single-strand DNA. The - and -MeFapy-dG anomers equilibrate over several days and reach a final ratio of ~21 : 79. The equilibration studies may provide insight to the conflicting reports by Asagoshi et al. regarding the Endo IV incision of the MeFapy-dG lesion in DNA. The MeFapy-dG-containing duplexes were prepared differently. Ishchenko et al. prepared the MeFapy-dG lesion by treating a single-stranded oligonucleotide containing a single dG with a methylating agent [32]; the resulting 7-methyl-dG was then subjected to base treatment to generate the MeFapy-dG lesion. Annealing of the MeFapy-dG-containing oligonucleotide is expected to contain both the - and -anomers as demonstrated in our studies. Asagoshi et al. prepared a DNA duplex by incorporating 7-methyl-dGTP opposite a template strand containing a single dC with a DNA polymerase [30, 31]; alkali treatment of the duplex produced the MeFapy-dG lesion. It is likely that ring opening of -7-methyl-dG in duplex DNA produced largely or exclusively the -MeFapy-dG anomer. We demonstrated that the anomerization of the -MeFapy-dG anomer is slow at pH 7.0 and is expected to be slower at pH 7.5, the conditions reported by Asagoshi et al. for the attempted Endo IV incision [30]. It is possible that the -MeFapy-dG anomer had not equilibrated when treated with Endo IV, and consequently, no incision was observed.

The MeFapy-dG lesion was shown to be the persistent DNA lesion in rats treated with methylnitrosourea, 1,2-dimethylhydrazine, and N,N-dimethylnitrosamine [8, 9]. The MeFapy-dG lesion was reported to be present 21 days after exposure; these studies detected the MeFapy-G base, thus information regarding the anomeric stereochemistry was lost. As noted above, the MeFapy-dG lesion is likely to be initially formed as the -anomer; our observation that -MeFapy-dG will slowly equilibrate to ~21% of the -anomer over 3–5 days suggests that the -anomer is present in cells due to the long-lived nature of this lesion and therefore may be biologically relevant.

3.4. Incision of AFB-Fapy-dG by Endo IV

The 24 mer oligonucleotide containing the AFB-Fapy-dG lesion, -ACCACTACTAT-(AFB-Fapy-dG)-ATTCATAACAAC , was synthesized as previously described, and the - and -AFB-Fapy-dG-containing oligonucleotides were separated by HPLC [38]. The oligonucleotide containing the -AFB-Fapy-dG lesion was -32P-end labeled and hybridized to its complementary strand in which the lesion was opposite dC. Treatment of this duplex (20 nM) with Endo IV (0.08 nM) under the same conditions used for incision of the MeFapy-dG-containing duplex resulted in ~5% incision of -AFB-Fapy-dG modified strand after 30 minute (Figure 7); the level of incision did not increase after 90 minute. The level of incision reached when the Endo IV concentration was increased by 10-fold.

The activity of Endo IV toward the AFB-Fapy-dG lesion was low in comparison to the MeFapy-dG lesion. The -AFB-Fapy-dG was reported to have completely isomerized to the -anomer over several days at pH 7.0 and C [37]. It is possible that the low level of incision observed for the AFB-Fapy-dG-containing 24 mer duplex was due to rapid isomerization of the -anomer to the ; however, HPLC analysis indicated that the level on the -AFB-Fapy-dG anomer was less than 5% over the 90 minute reaction time and conditions used to 32P-labeled the substrate. In Figure 1 a recent NMR structure of the -AFB-Fapy-dG leson in a -CTAT-(AFB-Fapy-dG)- ATTCA- · -TGAATCATAG- 10 mer duplex revealed that the AFB moiety was intercalated to the -side of the modified -Fapy-dG base [38] and well stacked (Figure 8). The modified -AFB-Fapy-dG base was paired with its complementary dC, and both bases were intrahelical. The 10 mer sequence possesses the same local sequence as the AFB-Fapy-dG containing 24 mer used in this study. The insertion of the Tyr-72 side chain of Endo IV into the DNA helix plays an important role in the recognition and catalytic mechanism by promoting the flipping of the abasic nucleotide along with its partner nucleotide into the active site of the enzyme, stabilizing a bend in the DNA and positioning the phosphate for hydrolysis. The position of the bulky AFB group may severely interfere with the binding of the substrate DNA to Endo IV and the incision reaction [22, 23]. Alternatively, a solvent accessible pocket in the active site of Endo IV is hypothesized to accommodate -nucleotides, and it is plausible that bulky lesions such as the -AFB-Fapy-dG cannot be readily accommodated in this pocket [22]. Chromatographic evidence for a minor conformation of the -AFB-Fapy-dG in single strand was reported [38]; the nature of this conformation is not clear but the possibilities include geometric isomers of the amide or atropisomers [14, 40, 42]. It is possible that Endo IV is selectively incising this minor -AFB-Fapy-dG conformer.

fig1
Figure 1: Structures of the methyl and aflatoxin B1 Fapy-dG lesions.
fig2
Figure 2: Gel electrophoretic analysis of the incision of the MeFapy-dG containing duplex with E. coli Endo IV. (a) Incision after the annealing of the -32P-labelled MeFapy-dG containing oligonucleotide (24 mer) with its complement. The right lane is a standard of the -32P-ACCACGCTAGC- incision product. (b) Percentage of the incision product after subsequent denaturation-reannealing and additional Endo IV.
850234.fig.003
Figure 3: Full-can mass spectrum of the Endo IV incision of the MeFapy-dG containing duplex; m/z 1825.4 [M-4H] and 1460.3 [M-5H] are the 5′-ACCACGCTAGC-(MeFapy-dG)-AGTCCTAACAAC-3′, m/z 1484.9 [M-5H] and 1237.2 [M-6H] are the 5′-GTTGTTAGGACTCGCTAGCGTGGT-3′, m/z 1094.1 [M-3H] and 820.3 [M-4H] are the 5′-ACCACGCTAGC-3′, and m/z 1345.2 [M-3H] and 1009.0 [M-4H]) is the 5′-p(MeFapy-dG)- AGTCCTAACAAC-3′ oligonucleotide.
fig4
Figure 4: Steady-state kinetic analysis for the incision of the MeFapy-dG-(a) and α-dG-(b) containing duplexes when the modified base was opposite dC. The Endo IV concentration was 0.08 nM.
fig5
Figure 5: Gel electrophoretic analysis of the equilibration of the - and α-MeFapy-dG anomers in duplex DNA. (a) Anomerization of the -MeFapy-dG after initial incision with Endo IV. Aliquots were treated with additional Endo IV every 24 h; the increase in the incision product is attributed to equilibration of the -MeFapy-dG to the -anomer. (b) Treatment of the MeFapy-dG-containing duplex with Endo IV after incubation at 37°C, pH 7.0 for up to 5 days.
850234.fig.006
Figure 6: Thermal melting analysis of the 12 mer duplex containing the MeFapy-dG lesion opposite dC after 5 days at 37°C. The Tm for the unmodied duplex was 59°C.
850234.fig.007
Figure 7: Gel electrophoretic analysis of the incision of the -AFB-Fapy-dG-containing 5′-32P-labeled 24 mer duplex by Endo IV. The right lane is a standard of the 5′-32P-ACCACTACTAT-3′ incision product.
850234.fig.008
Figure 8: Conformation of the -AFB-Fapy-dG-containing 10 mer duplex. The AFB moiety (magenta) was intercalated to the 5′-side of the Fapy-G base, which was paired with its complement (pdb code 2KH3).

4. Conclusion

We unambiguously observed that the -MeFapy-dG lesion is a substrate for Endo IV. This activity was exploited to probe the anomeric configuration of the MeFapy-dG lesion in duplex DNA. Endo IV was used to follow the equilibration of the - and -MeFapy-dG lesions, and we estimate the -ratio to be ~21 : 79. Although the equilibration was slow, it was faster than the repair of the MeFapy-dG lesion from the DNA of rats. We conclude that the -MeFapy-dG will be present in mammalian cells, and its repair and replication are therefore of interest. Only low levels of incision were observed for the -AFB-Fapy-dG-containing duplex. It is likely that the bulk of the AFB moiety, which was intercalated on the -side of the modified base, interferes with substrate recognition and the incision reaction by Endo IV.

The MeFapy-dG lesion has been shown to be a substrate for the Fpg/Nei family of glycosylases [3, 30, 4345]. It is possible that Endo IV and the Fpg/Nei glycosylases have distinct roles during the repair of the MeFapy-dG with Endo IV incising the -anomer and Fpg/Nei glycosylases excising the -anomer. The specificity of Endo IV for the -MeFapy-dG anomer may provide a valuable tool for uncovering the mechanistic details of the repair of MeFapy-dG and related lesions.

Acknowledgments

The authors thank Professor Marc M. Greenberg for helpful discussions. This work was supported by NIH Research Grants P01 ES05355 (Carmelo J. Rizzo and Michael P. Stone) and R01 CA55678 (Michael P. Stone), and Center Grant P30 ES00267 (Carmelo J. Rizzo and Michael P. Stone).

References

  1. M. M. Greenberg, “In vitro and in vivo effects of oxidative damage to deoxyguanosine,” Biochemical Society Transactions, vol. 32, no. 1, pp. 46–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Pluskota-Karwatka, “Modifications of nucleosides by endogenous mutagens-DNA adducts arising from cellular processes,” Bioorganic Chemistry, vol. 36, no. 4, pp. 198–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Dizdaroglu, G. Kirkali, and P. Jaruga, “Formamidopyrimidines in DNA: mechanisms of formation, repair, and biological effects,” Free Radical Biology and Medicine, vol. 45, no. 12, pp. 1610–1621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Tudek, “Imidazole ring-opened DNA purines and their biological significance,” Journal of Biochemistry and Molecular Biology, vol. 36, no. 1, pp. 12–19, 2003. View at Google Scholar · View at Scopus
  5. K. S. Gates, T. Nooner, and S. Dutta, “Biologically relevant chemical reactions of N7-alkylguanine residues in DNA,” Chemical Research in Toxicology, vol. 17, no. 7, pp. 839–856, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Boysen, B. F. Pachkowski, J. Nakamura, and J. A. Swenberg, “The formation and biological significance of N7-guanine adducts,” Mutation Research, vol. 678, no. 2, pp. 76–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. T. Burgdorf and T. Carell, “Synthesis, stability, and conformation of the formamidopyrimidine G DNA lesion,” Chemistry—A European Journal, vol. 8, no. 1, pp. 293–301, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. F. F. Kadlubar, D. T. Beranek, C. C. Weis, F. E. Evans, R. Cox, and C. C. Irving, “Characterization of the purine ring-opened 7-methylguanine and its persistence in rat bladder epithelial DNA after treatment with the carcinogen N-methylnitrosourea,” Carcinogenesis, vol. 5, no. 5, pp. 587–592, 1984. View at Google Scholar · View at Scopus
  9. D. T. Beranek, C. C. Weis, F. E. Evans, C. J. Chetsanga, and F. F. Kadlubar, “Identification of N5-methyl-N5-formyl-2,5,6-triamino-4-hydroxypyrimidine as a major adduct in rat liver DNA after treatment with the carcinogens, N,N-dimethylnitrosamine or 1,2-dimethylhydrazine,” Biochemical and Biophysical Research Communications, vol. 110, no. 2, pp. 625–631, 1983. View at Google Scholar · View at Scopus
  10. J. M. Essigmann, R. G. Croy, R. A. Bennett, and G. N. Wogan, “Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis,” Drug Metabolism Reviews, vol. 13, no. 4, pp. 581–602, 1982. View at Google Scholar · View at Scopus
  11. P. P. Christov, K. L. Brown, I. D. Kozekov, M. P. Stone, T. M. Harris, and C. J. Rizzo, “Site-specific synthesis and characterization of oligonucleotides containing an N6-(2-deoxy-D-erythro-pentofuranosyl)-2,6-diamino-3,4-dihydro-4- oxo-5-N-methylformamidopyrimidine lesion, the ring-opened product from N7-methylation of deoxyguanosine,” Chemical Research in Toxicology, vol. 21, no. 12, pp. 2324–2333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Büsch, J. C. Pieck, M. Ober et al., “Dissecting the differences between the α and β anomers of the oxidative DNA lesion FaPydG,” Chemistry—A European Journal, vol. 14, no. 7, pp. 2125–2132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Berger and J. Cadet, “Isolation and characterization of the radiation-induced degradation products of 2-deoxyguanosine in oxygen-free aqueous solutions,” Zeitschrift für Naturforschung, vol. 40, no. 11, pp. 1519–1531, 1985. View at Google Scholar
  14. M. Tomasz, R. Lipman, M. S. Lee, G. L. Verdine, and K. Nakanishi, “Reaction of acid-activated mitomycin C with calf thymus DNA and model guanines: elucidation of the base-catalyzed degradation of N7-alkylguanine nucleosides,” Biochemistry, vol. 26, no. 7, pp. 2010–2027, 1987. View at Google Scholar · View at Scopus
  15. K. B. Lesiak and K. T. Wheeler, “Formation of α-deoxyadenosine in polydeoxynucleotides exposed to ionizing radiation under anoxic conditions,” Radiation Research, vol. 121, no. 3, pp. 328–337, 1990. View at Google Scholar · View at Scopus
  16. A. Bonicel, N. Mariaggi, E. Hughes, and R. Teoule, “In vitro γ irradiation of DNA: identification of radioinduced chemical modifications of the adenine moiety,” Radiation Research, vol. 83, no. 1, pp. 19–26, 1980. View at Google Scholar · View at Scopus
  17. P. W. Doetsch and R. P. Cunningham, “The enzymology of apurinic/apyrimidinic endonucleases,” Mutation Research, vol. 236, no. 2-3, pp. 173–201, 1990. View at Google Scholar · View at Scopus
  18. D. Ramotar, “The apurinic-apyrimidinic endonuclease IV family of DNA repair enzymes,” Biochemistry and Cell Biology, vol. 75, no. 4, pp. 327–336, 1997. View at Google Scholar · View at Scopus
  19. S. Ljungquist, T. Lindahl, and P. Howard-Flanders, “Methyl methane sulfonate sensitive mutant of Escherichia coli deficient in an endonuclease specific for apurinic sites in deoxyribonucleic acid,” Journal of Bacteriology, vol. 126, no. 2, pp. 646–653, 1976. View at Google Scholar · View at Scopus
  20. S. M. Kerins, R. Collins, and T. V. McCarthy, “Characterization of an endonuclease IV 3-5 exonuclease activity,” Journal of Biological Chemistry, vol. 278, no. 5, pp. 3048–3054, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Golan, A. A. Ishchenko, B. Khassenov, G. Shoham, and M. K. Saparbaev, “Coupling of the nucleotide incision and 35 exonuclease activities in Escherichia coli endonuclease IV: structural and genetic evidences,” Mutation Research, vol. 685, no. 1-2, pp. 70–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. Hosfield, Y. Guan, B. J. Haas, R. P. Cunningham, and J. A. Tainer, “Structure of the DNA repair enzyme endonuclease IV and its DNA complex: double-nucleotide flipping at abasic sites and three-metal-ion catalysis,” Cell, vol. 98, no. 3, pp. 397–408, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. E. D. Garcin, D. J. Hosfield, S. A. Desai et al., “DNA apurinic-apyrimidinic site binding and excision by endonuclease IV,” Nature Structural and Molecular Biology, vol. 15, no. 5, pp. 515–522, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Ivanov, J. A. Tainer, and J. A. McCammon, “Unraveling the three-metal-ion catalytic mechanism of the DNA repair endonuclease IV,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 5, pp. 1465–1470, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Ide, K. Tedzuka, H. Shimzu et al., “α-Deoxyadenosine, a major anoxic radiolysis product of adenine in DNA, is a substrate for Escherichia coli endonuclease IV,” Biochemistry, vol. 33, no. 25, pp. 7842–7847, 1994. View at Google Scholar · View at Scopus
  26. J. M. Aramini, S. H. Cleaver, R. T. Pon, R. P. Cunningham, and M. W. Germann, “Solution structure of a DNA duplex containing an α-anomeric adenosine: insights into substrate recognition by endonuclease IV,” Journal of Molecular Biology, vol. 338, no. 1, pp. 77–91, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Gros, A. A. Ishchenko, H. Ide, R. H. Elder, and M. K. Saparbaev, “The major human AP endonuclease (Ape1) is involved in the nucleotide incision repair pathway,” Nucleic Acids Research, vol. 32, no. 1, pp. 73–81, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Daviet, S. Couvé-Privat, L. Gros et al., “Major oxidative products of cytosine are substrates for the nucleotide incision repair pathway,” DNA Repair, vol. 6, no. 1, pp. 8–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. N. Patro, K. Haraguchi, M. O. Delaney, and M. M. Greenberg, “Probing the configurations of formamidopyrimidine lesions Fapy · dA and Fapy · dG in DNA using endonuclease IV,” Biochemistry, vol. 43, no. 42, pp. 13397–13403, 2004. View at Google Scholar · View at Scopus
  30. K. Asagoshi, T. Yamada, H. Terato et al., “Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine,” Journal of Biological Chemistry, vol. 275, no. 7, pp. 4956–4964, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Asagoshi, H. Terato, Y. Ohyama, and H. Ide, “Effects of a guanine-derived formamidopyrimidine lesion on DNA replication. Translesion DNA synthesis, nucleotide insertion, and extension kinetics,” Journal of Biological Chemistry, vol. 277, no. 17, pp. 14589–14597, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. A. A. Ishchenko, G. Sanz, C. V. Privezentzev, A. V. Maksimenko, and M. Saparbaev, “Characterisation of new substrate specificities of Escherichia coli and Saccharomyces cerevisiae AP endonucleases,” Nucleic Acids Research, vol. 31, no. 21, pp. 6344–6353, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. F. Laspia and S. S. Wallace, “Excision repair of thymine glycols, urea residues, and apurinic sites in Escherichia coli,” Journal of Bacteriology, vol. 170, no. 8, pp. 3359–3366, 1988. View at Google Scholar · View at Scopus
  34. V. Gervais, J. A. H. Cognet, A. Guy, J. Cadet, R. Téoule, and G. V. Fazakerley, “Solution structure of N-(2-deoxy-D-erythro-pentofuranosyl)urea frameshifts, one intrahelical and the other extrahelical, by nuclear magnetic resonance and molecular dynamics,” Biochemistry, vol. 37, no. 4, pp. 1083–1093, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Dubey, G. Pratviel, A. Robert, and B. Meunier, “Convenient method for the preparation of 2-deoxyribosylurea by thymidine oxidation and NMR study of both anomers,” Nucleosides, Nucleotides and Nucleic Acids, vol. 20, no. 8, pp. 1463–1471, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Baillet and J.-P. Behr, “Deoxyribosylurea and deoxyribosylformamide oligonucleotides,” Tetrahedron Letters, vol. 36, no. 49, pp. 8981–8984, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Mao, Z. Deng, F. Wang, T. M. Harris, and M. P. Stone, “An intercalated and thermally stable FAPY adduct of aflatoxin B1 in a DNA duplex: structural refinement from 1H NMR,” Biochemistry, vol. 37, no. 13, pp. 4374–4387, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. K. L. Brown, M. W. Voehler, S. M. Magee, C. M. Harris, T. M. Harris, and M. P. Stone, “Structural perturbations induced by the α-anomer of the aflatoxin B1 formamidopyrimidine adduct in duplex and single-strand DNA,” Journal of the American Chemical Society, vol. 131, no. 44, pp. 16096–16107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. R. Marinelli, F. Johnson, C. R. Iden, and P.-L. Yu, “Synthesis of 1,N2-(1,3-propano)-2-deoxyguanosine and incorporation into oligodeoxynucleotides: a model for exocyclic acrolein-DNA adducts,” Chemical Research in Toxicology, vol. 3, no. 1, pp. 49–58, 1990. View at Google Scholar · View at Scopus
  40. K. L. Brown, J. Z. Deng, R. S. Iyer et al., “Unraveling the aflatoxin-FAPY conundrum: structural basis for differential replicative processing of isomeric forms of the formamidopyrimidine-type DNA adduct of aflatoxin B1,” Journal of the American Chemical Society, vol. 128, no. 47, pp. 15188–15199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. S. Stover, G. Chowdhury, H. Zang, F. P. Guengerich, and C. J. Rizzo, “Translesion synthesis past the C8- and N2-deoxyguanosine adducts of the dietary mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in the NarI recognition sequence by prokaryotic DNA polymerases,” Chemical Research in Toxicology, vol. 19, no. 11, pp. 1506–1517, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Boiteux, J. Belleney, B. P. Roques, and J. Laval, “Two rotameric forms of open ring 7-methylguanine are present in alkylated polynucleotides,” Nucleic Acids Research, vol. 12, no. 13, pp. 5429–5439, 1984. View at Google Scholar · View at Scopus
  43. S. Boiteux, T. R. O'Connor, F. Lederer, A. Gouyette, and J. Laval, “Homogeneous Escherichia coli FPG protein. A DNA glycosylase which excises imidazole ring-opened purines and nicks DNA at apurinic/apyrimidinic sites,” Journal of Biological Chemistry, vol. 265, no. 7, pp. 3916–3922, 1990. View at Google Scholar · View at Scopus
  44. A. Katafuchi, T. Nakano, A. Masaoka et al., “Differential specificity of human and Escherichia coli endonuclease III and VIII homologues for oxidative base lesions,” Journal of Biological Chemistry, vol. 279, no. 14, pp. 14464–14471, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Liu, V. Bandaru, J. P. Bond et al., “The mouse ortholog of NEIL3 is a functional DNA glycosylase in vitro and in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 11, pp. 4925–4930, 2010. View at Publisher · View at Google Scholar · View at Scopus